A comparative study of murine glioma synthesized CCL2 was reported to facilitate the recruitment of CCR2+ Ly6C+ monocytic MDSCs (M-MDSCs) to the tumor site, while CCL2-deficient tumor site witnessed a significant reduction in MDSCs infiltration [22]. The gene discussed is CCL2; the disease is glioma.